MEDIUM · 6.5

CVE-2022-30699

NLnet Labs Unbound, up to and including version 1.16.1, is vulnerable to a novel type of the "ghost domain names" attack. The vulnerability works by targeting an Unbound instance. Unbound is queried f...

Vulnerability Description

NLnet Labs Unbound, up to and including version 1.16.1, is vulnerable to a novel type of the "ghost domain names" attack. The vulnerability works by targeting an Unbound instance. Unbound is queried for a rogue domain name when the cached delegation information is about to expire. The rogue nameserver delays the response so that the cached delegation information is expired. Upon receiving the delayed answer containing the delegation information, Unbound overwrites the now expired entries. This action can be repeated when the delegation information is about to expire making the rogue delegation information ever-updating. From version 1.16.2 on, Unbound stores the start time for a query and uses that to decide if the cached delegation information can be overwritten.

CVSS Score

6.5

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
NONE
Availability
NONE

Affected Products

VendorProductVersions
NlnetlabsUnbound< 1.16.2
FedoraprojectFedora35

Related Weaknesses (CWE)

References

FAQ

What is CVE-2022-30699?

CVE-2022-30699 is a vulnerability with a CVSS score of 6.5 (MEDIUM). NLnet Labs Unbound, up to and including version 1.16.1, is vulnerable to a novel type of the "ghost domain names" attack. The vulnerability works by targeting an Unbound instance. Unbound is queried f...

How severe is CVE-2022-30699?

CVE-2022-30699 has been rated MEDIUM with a CVSS base score of 6.5/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-30699?

Check the references section above for vendor advisories and patch information. Affected products include: Nlnetlabs Unbound, Fedoraproject Fedora.